UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

C.04.02 What can we do to improve adherence to treatment in patients with schizophrenia?

European neuropsychopharmacology, 2013-10, Vol.23, p.S633-S633

Cañas, F

2013

Volltextzugriff (PDF)

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area

European psychiatry, 2009-10, Vol.24 (7), p.431-441

2009

Volltextzugriff (PDF)

C.10.01 Life-long treatment in patients with schizophrenia

European neuropsychopharmacology, 2009, Vol.19, p.S712-S713

Cañas, F

2009

Volltextzugriff (PDF)

Microbial origin of the Ordovician stromatoporoid-like organism Zondarella from the Argentine Precordillera and the post- Cambrian persistence of stromatolite microbialite reefs

Palaeogeography, palaeoclimatology, palaeoecology, 2023-10, Vol.627, p.111752, Article 111752

2023

Volltextzugriff (PDF)

C.20.02 Effective treatment of schizophrenia across the spectrum of age, severity and symptoms

European neuropsychopharmacology, 2008, Vol.18, p.S610-S611

Cañas, F

2008

Volltextzugriff (PDF)

Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe

European psychiatry, 2011-03, Vol.26 (1), p.17-28

2011

Volltextzugriff (PDF)

C.01.03 Implications of sustained effectiveness in managing schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S595-S596

Cañas, F

2007

Volltextzugriff (PDF)

Talus fractures. Functional results for polytraumatized patients

Revista española de cirugía ortopédica y traumatología (English ed.), 2019-09, Vol.63 (5), p.336-341

2019

Volltextzugriff (PDF)

Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups

European psychiatry, 2011-03, Vol.26 (1), p.3-16

2011

Volltextzugriff (PDF)

P.3.f.002 Epidemiologic naturalistic study to determine the relationship between the Personal and Social Performance (PSP) scale and the perceived sleep quality in schizophrenia

European neuropsychopharmacology, 2012-10, Vol.22, p.S356-S356

2012

Volltextzugriff (PDF)

P.3.a.017 Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey results

European neuropsychopharmacology, 2012-10, Vol.22, p.S313-S314

2012

Volltextzugriff (PDF)

Poster #186 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ VIEWS ON THE TREATMENT OPTIONS FOR IMPROVING PARTIAL OR NON-ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA

Schizophrenia research, 2012-04, Vol.136, p.S158-S158

2012

Volltextzugriff (PDF)

Poster #185 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ PERCEPTIONS OF THE EXTENT AND BURDEN OF PARTIAL AND NON-ADHERENCE TO MEDICATION IN PATIENTS WITH SCHIZOPHRENIA

Schizophrenia research, 2012-04, Vol.136, p.S157-S158

2012

Volltextzugriff (PDF)

PMH33 The Cost-Effectiveness of Paliperidone ER in Spain

Value in health, 2011, Vol.14 (7), p.A292-A292

2011

Volltextzugriff (PDF)

Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa

Frontiers in pharmacology, 2022-11, Vol.13, p.921511-921511

2022

Volltextzugriff (PDF)

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial

Schizophrenia research, 2007-02, Vol.90 (1), p.147-161

2007

Volltextzugriff (PDF)

Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections

Biomedicines, 2019-04, Vol.7 (2), p.34

2019

Volltextzugriff (PDF)

Intranasal immunization with dry powder vaccines

European journal of pharmaceutics and biopharmaceutics, 2018-01, Vol.122, p.167-175

2018

Volltextzugriff (PDF)

P03-275 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of reasons for partial or non-adherence

European psychiatry, 2011, Vol.26, p.1444-1444

2011

Volltextzugriff (PDF)

P03-277 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of the extent of assessment and management of partial and non-adherence to medication

European psychiatry, 2011, Vol.26, p.1446-1446

2011

Volltextzugriff (PDF)

P03-276 - The EMEA ADHES survey in schizophrenia, an initiative to raise awareness of non-adherence to medication. demographics and methodology

European psychiatry, 2011, Vol.26, p.1445-1445

2011

Volltextzugriff (PDF)

Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process

Pharmaceutics, 2021-07, Vol.13 (7), p.1051

2021

Volltextzugriff (PDF)

Profile of the schizophrenic patient treated with aripiprazole in Spain. REA study

European psychiatry, 2007-03, Vol.22, p.S135-S135

2007

Volltextzugriff (PDF)

Retrospective, observational, post-authorization study to obtain a second profile of schizophrenic patients treated with aripiprazole in Spain. Study REA II

European psychiatry, 2007-03, Vol.22, p.S135-S135

2007

Volltextzugriff (PDF)

The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

Scientific reports, 2020-11, Vol.10 (1), p.20433-20433, Article 20433

2020

Volltextzugriff (PDF)

1 – 25 von 397

Suche als RSS-Feed

Aktive Filter

KollektionIngenta.com

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(379)
Mit Volltextzugriff
(343)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(222)
Life Sciences & Biomedicine
(167)
Humans
(126)
Female
(94)
Male
(88)
Adult
(76)
Middle Aged
(70)
Biological And Medical Sciences
(52)
Technology
(44)
Aged
(42)
Medical Sciences
(41)
Internal Medicine
(32)
Physical Sciences
(32)
Psychiatry
(32)
Adolescent
(26)
Exact Sciences And Technology
(23)
Physics
(23)
Materials Science
(21)
Fundamental And Applied Biological Sciences. Psychology
(20)
Treatment Outcome
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

C.04.02 What can we do to improve adherence to treatment in patients with schizophrenia?

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area

C.10.01 Life-long treatment in patients with schizophrenia

Microbial origin of the Ordovician stromatoporoid-like organism Zondarella from the Argentine Precordillera and the post- Cambrian persistence of stromatolite microbialite reefs

C.20.02 Effective treatment of schizophrenia across the spectrum of age, severity and symptoms

Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe

C.01.03 Implications of sustained effectiveness in managing schizophrenia

Talus fractures. Functional results for polytraumatized patients

Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups

P.3.f.002 Epidemiologic naturalistic study to determine the relationship between the Personal and Social Performance (PSP) scale and the perceived sleep quality in schizophrenia

P.3.a.017 Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey results

Poster #186 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ VIEWS ON THE TREATMENT OPTIONS FOR IMPROVING PARTIAL OR NON-ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA

Poster #185 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ PERCEPTIONS OF THE EXTENT AND BURDEN OF PARTIAL AND NON-ADHERENCE TO MEDICATION IN PATIENTS WITH SCHIZOPHRENIA

PMH33 The Cost-Effectiveness of Paliperidone ER in Spain

Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial

Current Status of In Vitro Models and Assays for Susceptibility Testing for Wound Biofilm Infections

Intranasal immunization with dry powder vaccines

P03-275 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of reasons for partial or non-adherence

P03-277 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of the extent of assessment and management of partial and non-adherence to medication

P03-276 - The EMEA ADHES survey in schizophrenia, an initiative to raise awareness of non-adherence to medication. demographics and methodology

Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process

Profile of the schizophrenic patient treated with aripiprazole in Spain. REA study

Retrospective, observational, post-authorization study to obtain a second profile of schizophrenic patients treated with aripiprazole in Spain. Study REA II

The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

Aktive Filter

Suchergebnisse filtern